- NuCana stock falls 21% after company suspends patient enrollment in pancreatic cancer trial
- Medtronic’s stock surges to record, paces S&P 500 gainers after upbeat results and outlook
- TherapeuticsMD stock slides 6% after SEC charges company with breaking disclosure rules
- Cemtrex stock soars to lead Nasdaq gainers after Q2 results
- Italy’s Giuseppe Conte set to step down soon
